Querfeld C - Search Results

1

Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome.

Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Martinez XU, et al. Among authors: querfeld c. Best Pract Res Clin Haematol. 2019 Sep;32(3):239-252. doi: 10.1016/j.beha.2019.06.004. Epub 2019 Jun 6. Best Pract Res Clin Haematol. 2019. PMID: 31585624 Free PMC article. Review.

2

Primary cutaneous lymphomas: a review with current treatment options.

Querfeld C, Guitart J, Kuzel TM, Rosen ST. Querfeld C, et al. Blood Rev. 2003 Sep;17(3):131-42. doi: 10.1016/s0268-960x(03)00004-3. Blood Rev. 2003. PMID: 12818223 Review.

3

Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.

Querfeld C, Rosen ST, Kuzel TM, Guitart J. Querfeld C, et al. Semin Cutan Med Surg. 2003 Sep;22(3):150-61. doi: 10.1016/S1085-5629(03)00041-5. Semin Cutan Med Surg. 2003. PMID: 14649582 Review.

4

Cutaneous T-cell lymphoma: a paradigm for biological therapies.

Pichardo DA, Querfeld C, Guitart J, Kuzel TM, Rosen ST. Pichardo DA, et al. Among authors: querfeld c. Leuk Lymphoma. 2004 Sep;45(9):1755-65. doi: 10.1080/10428190410001693560. Leuk Lymphoma. 2004. PMID: 15223633 Review.

5

Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma.

Querfeld C, Rosen ST, Guitart J, Rademaker A, Fung BB, Posten W, Kuzel TM. Querfeld C, et al. J Am Acad Dermatol. 2004 Jul;51(1):25-32. doi: 10.1016/j.jaad.2003.11.058. J Am Acad Dermatol. 2004. PMID: 15243520 Clinical Trial.

6

Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.

Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH Jr, Prinz BM, Guitart J. Querfeld C, et al. Arch Dermatol. 2005 Mar;141(3):305-11. doi: 10.1001/archderm.141.3.305. Arch Dermatol. 2005. PMID: 15781671

7

The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy.

Querfeld C, Rosen ST, Guitart J, Kuzel TM. Querfeld C, et al. Curr Opin Hematol. 2005 Jul;12(4):273-8. doi: 10.1097/01.moh.0000166498.64515.03. Curr Opin Hematol. 2005. PMID: 15928483 Review.

8

Bexarotene in the treatment of cutaneous T-cell lymphoma.

Querfeld C, Nagelli LV, Rosen ST, Kuzel TM, Guitart J. Querfeld C, et al. Expert Opin Pharmacother. 2006 May;7(7):907-15. doi: 10.1517/14656566.7.7.907. Expert Opin Pharmacother. 2006. PMID: 16634713 Review.

9

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.

Querfeld C, Rizvi MA, Kuzel TM, Guitart J, Rademaker A, Sabharwal SS, Krett NL, Rosen ST. Querfeld C, et al. J Invest Dermatol. 2006 Jul;126(7):1641-7. doi: 10.1038/sj.jid.5700322. Epub 2006 Apr 27. J Invest Dermatol. 2006. PMID: 16645590 Free article.

10

T-cell non-Hogdkin's lymphoma.

Evens AM, Querfeld C, Rosen ST. Evens AM, et al. Among authors: querfeld c. Cancer Treat Res. 2006;131:161-220. Cancer Treat Res. 2006. PMID: 16704170 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page